CD4 and tuberculosis: Among patients with available CD4 data prior to DR‐TB treatment start, 36/78 (46%) had CD4 < 200 cells/μL; of those who received any ART within 6 months prior to DR‐TB treatment start, 23/39 of patients (59%) had CD4 < 200 cells/μL compared with 13/39 (33%) not receiving ART (p = 0.02).